Medpace Holdings EBITDA Margin 2014-2024 | MEDP
Medpace Holdings EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2024-03-31 | $1.96B | $0.38B | 19.47% |
2023-12-31 | $1.89B | $0.36B | 19.26% |
2023-09-30 | $1.78B | $0.35B | 19.71% |
2023-06-30 | $1.67B | $0.34B | 20.50% |
2023-03-31 | $1.56B | $0.32B | 20.73% |
2022-12-31 | $1.46B | $0.30B | 20.62% |
2022-09-30 | $1.38B | $0.28B | 20.36% |
2022-06-30 | $1.29B | $0.26B | 19.81% |
2022-03-31 | $1.21B | $0.24B | 19.52% |
2021-12-31 | $1.14B | $0.22B | 19.34% |
2021-09-30 | $1.09B | $0.22B | 20.11% |
2021-06-30 | $1.03B | $0.21B | 20.62% |
2021-03-31 | $0.96B | $0.20B | 20.84% |
2020-12-31 | $0.93B | $0.19B | 20.09% |
2020-09-30 | $0.90B | $0.17B | 18.64% |
2020-06-30 | $0.88B | $0.15B | 17.12% |
2020-03-31 | $0.89B | $0.16B | 17.62% |
2019-12-31 | $0.86B | $0.15B | 17.54% |
2019-09-30 | $0.82B | $0.15B | 18.23% |
2019-06-30 | $0.79B | $0.15B | 18.45% |
2019-03-31 | $0.74B | $0.14B | 18.46% |
2018-12-31 | $0.70B | $0.13B | 18.89% |
2018-09-30 | $0.63B | $0.11B | 17.76% |
2018-06-30 | $0.56B | $0.11B | 19.75% |
2018-03-31 | $0.49B | $0.11B | 21.30% |
2017-12-31 | $0.44B | $0.10B | 23.57% |
2017-09-30 | $0.43B | $0.11B | 26.16% |
2017-06-30 | $0.43B | $0.11B | 26.11% |
2017-03-31 | $0.43B | $0.11B | 26.34% |
2016-12-31 | $0.42B | $0.11B | 26.78% |
2016-06-30 | $0.30B | $0.06B | 21.48% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.076B | $1.886B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $125.431B | 15.74 |
Cencora (COR) | United States | $47.828B | 19.09 |
ICON (ICLR) | Ireland | $24.755B | 23.37 |
DiDi Global (DIDIY) | China | $23.950B | 0.00 |
Avantor (AVTR) | United States | $17.059B | 23.50 |
Viatris (VTRS) | United States | $13.760B | 3.93 |
CochLear (CHEOY) | $13.446B | 0.00 | |
Revvity (RVTY) | United States | $12.611B | 21.95 |
Charles River Laboratories (CRL) | United States | $11.735B | 21.39 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.550B | 0.00 |
Natera (NTRA) | United States | $11.158B | 0.00 |
Solventum (SOLV) | United States | $10.666B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.782B | 50.67 |
Bausch + Lomb (BLCO) | Canada | $5.187B | 19.95 |
Organon (OGN) | United States | $4.709B | 4.56 |
Doximity (DOCS) | United States | $4.401B | 32.76 |
PACS (PACS) | United States | $3.643B | 0.00 |
Sotera Health (SHC) | United States | $3.204B | 15.72 |
Surgery Partners (SGRY) | United States | $3.145B | 29.22 |
Progyny (PGNY) | United States | $3.124B | 52.42 |
GoodRx Holdings (GDRX) | United States | $2.797B | 141.60 |
Life Times (LTH) | United States | $2.776B | 30.67 |
Premier (PINC) | United States | $2.493B | 9.13 |
Teladoc Health (TDOC) | United States | $2.257B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.131B | 6.89 |
Agilon Health (AGL) | United States | $2.109B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.782B | 0.00 |
Agiliti (AGTI) | United States | $1.366B | 22.31 |
Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.316B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.975B | 0.00 |
Pediatrix Medical (MD) | United States | $0.748B | 7.74 |
Embecta (EMBC) | United States | $0.599B | 3.95 |
Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
Enhabit (EHAB) | United States | $0.495B | 44.86 |
COMPASS Pathways (CMPS) | United Kingdom | $0.487B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
LifeMD (LFMD) | United States | $0.437B | 0.00 |
CareDx (CDNA) | United States | $0.391B | 0.00 |
Beauty Health (SKIN) | United States | $0.378B | 0.00 |
MultiPlan (MPLN) | United States | $0.368B | 0.00 |
DocGo (DCGO) | United States | $0.364B | 58.17 |
ModivCare (MODV) | United States | $0.340B | 4.51 |
Sera Prognostics (SERA) | United States | $0.335B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.291B | 0.00 |
Sharecare (SHCR) | United States | $0.266B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.256B | 0.00 |
Biodesix (BDSX) | United States | $0.145B | 0.00 |
So-Young (SY) | China | $0.123B | 41.33 |
Oncology Institute (TOI) | United States | $0.088B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.076B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.032B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
DermTech (DMTK) | United States | $0.020B | 0.00 |
OncoCyte (OCX) | United States | $0.020B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.015B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |